Moderna, Inc MRNA

sfhenderson17

I was playing both sides, puts won big. The downside now is pretty big, last drop was around $225, this time could go sub $200. I'll take profits end of day on puts, but might grab a next week $200 put or a spread to get a little more exposure if we fall harder.

dRends35

When is the trend your friend until? This should see $160 and perhaps much lower. Not advice.

bsdvs23

I've been waiting for MRNA to have some stabilization during it's pullbacks -- now is the time in my opinion. For pharmaceutical companies the vaccines have been their "bread and butter" and they'll ensure they continue to innovate through a variety of new accommodations for people around the world pertaining to Covid, HIV, and anything else they can acquire...

rion_h2

I'm thinking after the cup and handle pattern we might see a reversal. My prediction is that itll pass resistance with ease and bounce off resistance after hitting the $370-ish mark, then potentially new highs.

sfhenderson17

We got the big bounce on renewed fears of COVID, then a pullback with the market weakness. Now to decide, is this market pullback about COVID? If so, this should bounce again, close to $400+ maybe, if not, then the weakness could pull us all the way back to the last low point. For now I have a $400 call and a $270 put for next week. Let's see how end of week goes

scavoanastasiia

Last week ended with sell-offs amid fears about the new extremely contagious COVID 19 Omicron variant. Crude and stock markets suffered. But during this brief rally some shares continued to gain, and it is no wonder that these are the stocks of vaccine producers. Pfizer stocks posted a new all-time high on Friday rising by 6.11% to $54.94. Stocks were...

DarkPoolTrading

Idea for MRNA: - Contrarian bet - Investors believing that Nu variant will be a boon for Moderna and vaccine stocks. - I think the opposite. Exit for Vaccine pump and dumpers before the bear market. - Either the Nu var is a ruse, and we dont need boosters (bearish MRNA) - Or Nu var is resistant to all vaccines (bearish MRNA) Either way, very cheap to fade it...

Rocky88888888888

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising...

shkspr

NASDAQ:MRNA Possible Scenario: LONG Evidence: Price action, dark pool, money-flow TP1: 361$ TP2: 380$ TP3: 405$ TP4: ATH at 500$ Timeframe before 17th Dec Call options Strike 350$ or 400$ for 17th Dec. *This is my idea and could be wrong 100%

AllAboutMoney

i dont like this stock, because $MRK pill will change everything but, this is maybe a good time to buy,

SaeedSajedi

MRNA is experiencing very tough moments ! It lost three strong supports in a single day ! This is how lower than expectations earning reports destroy the stocks ! Chart is showing everything my friends. We always choose our long positions smartly. Don't we? Good luck

hngng_anhs

waiting to retrace and long ...........................................................................

Morbius_Murphy

What is causation and correlation? We can see that this stock was heading down and perfectly hit the .618 fib. Then the stock needed an extra boost, so come Nov. 26th they "release" news about a new variant to help prop up the stock. When you can control the news, narrative and fear you move markets and money. The added suppression of negative vx news, this helps...

MrMercato

Moderna looks oversold and potential rebound to $ 275 - 280 level ( fill the gap). the idea is : Buy call option strike $260 /Nov 19 @ 0.45 I'm already in 20 calls.

asifmatin

MRNA is heading higher, don't sell, hold it until 520, we may get it by Dec 20th, 2021, next resistance is 376.

GroundNinja

MRNA: Pure momentum monster leading the index today with a move +25.83% while the market touches new lows. The +66 pt move brings it back to a key level of its 50SMA and critical re-establishment on previously auctioned price shelves. MRNA holds its upside contingent on variant mutation news & uncertainty// ATR: 17.73, Beta: .1482

scavoanastasiia

Pfizer is now outperforming Merck and Moderna stocks after announcing its anti-COVID pill despite its shares not being the best option for investments in the first half of this year. Pfizer stocks gained only 35% since the beginning of this year until mid-August. Moderna stocks were skyrocketed by 375% for the same period. So, undoubtedly Moderna was the...

KevinBurrows

Earnings tomorrow pre-market. There is a 25 point move priced in.